Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-001141
Filing Date
2021-02-17
Accepted
2021-02-17 16:37:42
Documents
122
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bpmc-20201231x10k.htm   iXBRL 10-K 3134635
2 EX-10.32 bpmc-20201231xex10d32.htm EX-10.32 33474
3 EX-21.1 bpmc-20201231xex21d1.htm EX-21.1 11724
4 EX-23.1 bpmc-20201231xex23d1.htm EX-23.1 6468
5 EX-31.1 bpmc-20201231xex31d1.htm EX-31.1 12148
6 EX-31.2 bpmc-20201231xex31d2.htm EX-31.2 12387
7 EX-32.1 bpmc-20201231xex32d1.htm EX-32.1 10349
8 GRAPHIC bpmc-20201231x10k006.jpg GRAPHIC 5456
9 GRAPHIC bpmc-20201231x10k007.jpg GRAPHIC 64173
  Complete submission text file 0001558370-21-001141.txt   11878599

Data Files

Seq Description Document Type Size
10 EX-101.SCH bpmc-20201231.xsd EX-101.SCH 83631
11 EX-101.CAL bpmc-20201231_cal.xml EX-101.CAL 90124
12 EX-101.DEF bpmc-20201231_def.xml EX-101.DEF 311957
13 EX-101.LAB bpmc-20201231_lab.xml EX-101.LAB 707353
14 EX-101.PRE bpmc-20201231_pre.xml EX-101.PRE 617458
15 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20201231x10k_htm.xml XML 1935833
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37359 | Film No.: 21645398
SIC: 2834 Pharmaceutical Preparations